For example, Garfall et al. determined that the CD27+CD45RO-CD8+ T cell subpopulation predicting treatment success was significantly less enriched in relapsed cases of multiple myeloma, relative to primary cases (16). This evidence concerns the gene CD8A and plasma cell myeloma.